NOVO NORDISK (NVO.N) CEO said liver disease is an obvious entry point and, despite recent setbacks, cardiovascular remains another clear strategic focus.

2026-09-21

NOVO NORDISK (NVO.N) CEO said liver disease is an obvious entry point and, despite recent setbacks, cardiovascular remains another clear strategic focus.

其他消息